KRPIA Holds '2022 Ethics Management Workshop'

On-site at the Ethical Management Workshop of the Korea Research-based Pharmaceutical Industry Association (KRPIA). [Photo by KRPIA]

[Asia Economy Reporter Lee Gwan-ju] The Korea Research-based Pharmaceutical Industry Association (KRPIA) announced on the 21st that it held the '2022 KRPIA Ethics Management Workshop' to enhance ethical management of global pharmaceutical companies.

Held in a hybrid format both online and offline for the first time in three years since COVID-19, the workshop was attended by about 150 compliance and legal officers from global pharmaceutical companies.

The workshop featured lectures and presentations on various topics including ▲pharmaceutical policy trends ▲the pros and cons in the introduction and application process of the U.S. Sunshine Act ▲a comparative legal study on the scope of pharmaceutical patent rights ▲introduction of compliance obligations under Supreme Court precedents and current pharmaceutical compliance issues ▲updates on digital healthcare and the latest issues in personal information protection.

Lee Young-shin, Vice Chairman of KRPIA, said, "We are proud that our member companies have adapted to environmental changes while maintaining a very high level of compliance monitoring activities," adding, "Although there are concerns ahead of the disclosure of expenditure reports, I believe we can overcome this together well."

This content was produced with the assistance of AI translation services.